SPONSOR
Astellas Pharma Global Development, Inc.
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 3
Conditions studied: Healthy VolunteerUrothelial CancerUrinary Bladder NeoplasmsPancreatic CancerMetastatic Pancreatic CancerMetastatic Pancreatic AdenocarcinomaAdvanced Solid Tumors
Astellas Pharma Global Development, Inc. is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Healthy Volunteer, Urothelial Cancer, Urinary Bladder Neoplasms, Pancreatic Cancer.
The trial portfolio spans Phase 1, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Astellas Pharma Global Development, Inc.
How many clinical trials has Astellas Pharma Global Development, Inc. sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Astellas Pharma Global Development, Inc., of which 4 are actively recruiting participants. These trials cover conditions including Healthy Volunteer, Urothelial Cancer, Urinary Bladder Neoplasms. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Astellas Pharma Global Development, Inc. research focus on?
Astellas Pharma Global Development, Inc. clinical trials span Healthy Volunteer, Urothelial Cancer, Urinary Bladder Neoplasms, Pancreatic Cancer, Metastatic Pancreatic Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Astellas Pharma Global Development, Inc. clinical trial?
To participate in a Astellas Pharma Global Development, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Astellas Pharma Global Development, Inc. trials with current recruitment status updated daily.
Clinical Trials by Astellas Pharma Global Development, Inc.
NCT07395024 Phase 1
Recruiting
A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults
Healthy Volunteer
NCT07566156 Phase 3
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Urothelial Cancer
NCT07409272 Phase 3
Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Pancreatic Cancer
NCT05719558 Phase 1
Recruiting
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Advanced Solid Tumors
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology